O'Brien Greene & Co. Inc Pfizer Inc Transaction History

O'Brien Greene & Co. Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $668,581 - $773,532	-18,510 Reduced 66.67%	9,255 $339,000
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $656,878 - $759,992	18,186 Added 189.85%	27,765 $1.02 Million
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $28,203 - $36,716	-716 Reduced 6.95%	9,579 $391,000
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $899,587 - $1.17 Million	-21,547 Reduced 67.67%	10,295 $527,000
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $928,937 - $1.13 Million	21,228 Added 200.0%	31,842 $1.39 Million
Q1 2022 May 18, 2022	SELL	$45.75 - $56.69 $64,050 - $79,366	-1,400 Reduced 11.65%	10,614 $549,000
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $82 - $122	-2 Reduced 0.02%	12,014 $709,000
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $216,417 - $275,192	6,466 Added 116.5%	12,016 $442,000
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $176,212 - $206,737	5,550 New	5,550 $204,000
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $214,574 - $260,310	-7,124 Closed	0 $0
Q2 2019 Aug 21, 2019	SELL	$36.98 - $41.52 $75,254 - $84,493	-2,035 Reduced 22.22%	7,124 $308,000
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $21,675 - $23,813	-578 Reduced 5.94%	9,159 $389,000
Q4 2018 Feb 27, 2019	BUY	$38.47 - $43.86 $374,582 - $427,064	9,737 New	9,737 $425,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of O'Brien Greene & Co. Inc, based on Form 13F filings with the SEC.

Stay updated on O'Brien Greene & Co. Inc with notifications on news.